yellox mediwin limited 0,9 mg/ml col·liri solució 5 ml
بيكالوتاميد تيڤع ٥٠ ملغ
teva pharmaceutical indust.ltd - bicalutamide 50 mg - tablets - bicalutamide - for the treatment of advanced prostate cancer in combination with lhrh analog therapy or surgical castration.
بيكالوتاميد تيڤع ١٥٠ ملغ
teva pharmaceutical indust.ltd - bicalutamide 150 mg - tablets - bicalutamide - in patients with locally advanced prostate cancer (t3-t4 any n m0 t1-t2 n+ m0) bicalutamide is indicated as immediate therapy either alone or as adjuvant to treatment by radical prostatectomy or radiotherapy. the management of patients with locally advanced non-metastatic prostate cancer for whom surgical castration or other medical intervention is not considered appropriate or acceptable.
روپينيرول تيڤع ٢ ملغ
teva pharmaceutical indust.ltd - ropinirole as hydrochloride 2 mg - film coated tablets - ropinirole - treatment of idiopathic parkinson's disease : ropinirole may be used alone in the treatment of idiopathic parkinson's disease.addition of ropinirole to levodopa may be used to control " on - off " fluctuations and permit a reduction in the total daily dose of levodopa.
paracetamol kern pharma 100mg/ml fr 30ml g0tas oral solucion efg
paracetamol kern pharma 100mg/ml fr 60ml go or solucion efg
troxerutina kern pharma 100 mg/ml solucion oral efg, 1 frasco de 200 ml
terlipresina acetato ever pharma 1 mg solución inyectable 5 viales
terlipresina acetato ever pharma 2 mg solución inyectable 5 viales
moxifloxacino kern pharma 0,5% col·liri 1 flascó solució 5 ml